Literature DB >> 335659

[Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus].

G I Aleksandrova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 335659

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN： 0507-4088


× No keyword cloud information.
  10 in total

1.  Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.

Authors:  Daniil A Korenkov; Karen L Laurie; Patrick C Reading; Louise A Carolan; Kok Fei Chan; Irina I Isakova-Sivak; Tatiana A Smolonogina; Kanta Subbarao; Ian G Barr; Julie Villanueva; Svetlana Shcherbik; Tatiana Bousse; Larisa G Rudenko
Journal:  Infect Genet Evol       Date:  2018-06-19       Impact factor: 3.342

2.  Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.

Authors:  Irina Isakova-Sivak; Daniil Korenkov; Tatiana Smolonogina; Tatiana Tretiak; Svetlana Donina; Andrey Rekstin; Anatoly Naykhin; Svetlana Shcherbik; Nicholas Pearce; Li-Mei Chen; Tatiana Bousse; Larisa Rudenko
Journal:  Virology       Date:  2016-11-06       Impact factor: 3.616

3.  Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.

Authors:  Svetlana Shcherbik; Sheila B Sergent; William G Davis; Bo Shu; John Barnes; Irina Kiseleva; Natalie Larionova; Alexander Klimov; Tatiana Bousse
Journal:  J Virol Methods       Date:  2013-09-18       Impact factor: 2.014

4.  H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.

Authors:  Jørgen de Jonge; Irina Isakova-Sivak; Harry van Dijken; Sanne Spijkers; Justin Mouthaan; Rineke de Jong; Tatiana Smolonogina; Paul Roholl; Larisa Rudenko
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

5.  Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.

Authors:  Svetlana Shcherbik; Nicholas Pearce; Irina Kiseleva; Natalie Larionova; Larisa Rudenko; Xiyan Xu; David E Wentworth; Tatiana Bousse
Journal:  J Virol Methods       Date:  2015-10-28       Impact factor: 2.014

6.  Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.

Authors:  Andrey Rekstin; Irina Isakova-Sivak; Galina Petukhova; Daniil Korenkov; Igor Losev; Tatiana Smolonogina; Tatiana Tretiak; Svetlana Donina; Svetlana Shcherbik; Tatiana Bousse; Larisa Rudenko
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

7.  Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.

Authors:  Svetlana Shcherbik; Nicholas Pearce; Amanda Balish; Joyce Jones; Sharmi Thor; Charles Todd Davis; Melissa Pearce; Terrence Tumpey; David Cureton; Li-Mei Chen; Julie Villanueva; Tatiana L Bousse
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines.

Authors:  Svetlana V Shcherbik; Nicholas C Pearce; Marnie L Levine; Alexander I Klimov; Julie M Villanueva; Tatiana L Bousse
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

9.  Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

Authors:  Larisa Rudenko; Irina Kiseleva; Anatoly N Naykhin; Marianna Erofeeva; Marina Stukova; Svetlana Donina; Galina Petukhova; Maria Pisareva; Vera Krivitskaya; Michael Grudinin; Zhanna Buzitskaya; Irina Isakova-Sivak; Svetlana Kuznetsova; Natalie Larionova; Julia Desheva; Irina Dubrovina; Alexandra Nikiforova; John C Victor; Kathy Neuzil; Jorge Flores; Vadim Tsvetnitsky; Oleg Kiselev
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

10.  Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

Authors:  Irina Isakova-Sivak; Jørgen de Jonge; Tatiana Smolonogina; Andrey Rekstin; Geert van Amerongen; Harry van Dijken; Justin Mouthaan; Paul Roholl; Victoria Kuznetsova; Elena Doroshenko; Vadim Tsvetnitsky; Larisa Rudenko
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.